Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Activation of GABBR1 by New Ligand Valerate Transcriptionally Regulates ATF4-NRF2-CXCL13 Axis Mediating CD8<sup>+</sup> T Cell Anti-Tumor Immunity.

International journal of biological sciences·2026

Same author

Effects of anodal transcranial direct current stimulation on athletic performance among elite athletes: A systematic review and meta-analysis.

Behavioural brain research·2026

Same author

Evolutionary convergence and divergence of hippocampal cytoarchitecture between rodents and primates revealed by single-cell spatial transcriptomics.

National science review·2026

Same author

Self-replication of DNA cross-tile patterns from temperature-selected species.

Nanoscale·2026

Same author

Rapid and Visual Detection of <i>Coxsackievirus A6</i> Using Reverse Transcription Multiple Cross Displacement Amplification Combined with Nanoparticle-Based Biosensor Platform.

ACS infectious diseases·2026

Same author

D2Rs Agonist Ropinirole Cooperates with Metformin to Modulate Thermogenesis and Ameliorate Obesity-Related Metabolic Disorders in Mice.

Diabetes & metabolism journal·2026

Same journal

Ketohexokinase: A central mediator of fructose-associated pathogenesis and promising therapeutic target.

Pharmacological research·2026

Same journal

GLP-1-based combination strategies for weight loss: Multi-target agents and combination therapies.

Pharmacological research·2026

Same journal

Cajaninstilbene acid in macrophage immunometabolism and angiogenesis: Mechanisms and therapeutic potential.

Pharmacological research·2026

Same journal

From Mechanisms to Therapy: Targeting the Gut-Brain Axis in Chronic Gastrointestinal Pain.

Pharmacological research·2026

Same journal

Natural product emodin-based nanodrug delivery systems: Advancements and applications.

Pharmacological research·2026

Same journal

Targeting androgen receptor transcriptionally represses VCP and enhances the efficacy of oncolytic-immunotherapy in hepatocellular carcinoma.

Pharmacological research·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Sep 20, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Bacteria-based nanodrug for anticancer therapy.

Ya-Jia Xie¹, Min Huang¹, Dan Li²

¹Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.

Pharmacological Research

|June 6, 2022

Summary

This summary is machine-generated.

Bacteria-based immunotherapy leverages bacterial properties to stimulate immune responses against cancer. Combining bacteria with nanotechnology enhances drug delivery and efficacy for improved cancer treatment strategies.

Keywords:

Anticancer Bacteria Bacteriotherapy Immunotherapy Nanotechnology

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

Related Experiment Videos

Last Updated: Sep 20, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

Area of Science:

Oncology
Immunology
Nanotechnology

Background:

Bacteria-based immunotherapy shows promise for cancer treatment by stimulating innate and adaptive immunity.
Bacteriolytic therapy utilizes bacteria that target the tumor microenvironment (TME), releasing cytotoxic and immune-modulating factors.
Cancer's complexity often requires combination therapies, as single treatments are insufficient for tumor eradication.

Purpose of the Study:

To explore the potential of combining bacteria with nanotechnology for enhanced cancer immunotherapy.
To investigate how nano-bacterial therapy can improve drug delivery and immune responses in cancer treatment.
To evaluate the efficacy of nano-bacterial mediated antitumor systems in conjunction with modern therapies.

Main Methods:

Review of current research on bacteria-based immunotherapy and nanotechnology applications in cancer.
Analysis of the mechanisms by which bacteria and their products exert antitumor effects.
Examination of the synergistic potential of combining nano-bacterial therapy with conventional cancer treatments.

Main Results:

Nano-bacterial therapy enhances drug permeability, retention, and tolerability.
This approach promotes immune cell mediator release and induces immunogenic cell death pathways.
Combination of nano-bacterial systems with modern therapies offers a promising strategy to overcome treatment barriers.

Conclusions:

Nano-bacterial therapy presents unique advantages by preserving bacterial features while offering enhanced therapeutic properties.
Combining nano-bacterial mediated systems with modern therapies can achieve satisfactory antitumor efficacy.
Further exploration of bacteria's immune-antitumor characteristics can lead to novel adjuvant treatment strategies for cancer.